Share

In This Section

Home / Blurb / Discussion Detail

Sanofi Announces Permanent J-Code for Isatuximab-irfc

On October 1, 2020, the isatuximab-irfc (Sarclisa®, Sanofi Genzyme) healthcare common procedure coding system (HCPCS) level II J code (J9227) will be effective. 

Read the one pager

Posted 9/18/2020